Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A side-by-side look at Sp 500 Equity and Multi Asset Retirement allocations, examining growth potential, risk, and diversification for retirement planning.
27,235 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
SpaceX grabs headlines, yet smart investors look for real performance. Meet two growth stocks I prefer over the hype:...
Carvana stock has faced a rough start to 2026, with the headline move being a sizable drop. This guide breaks down wh...
Meet MIB: Vimal Kapur, Chairman and CEO of Honeywell, as we dive into his plan to split the company into three units ...
A snack brand’s take-private deal sent its stock surging and offered a clear lesson for investors. This guide breaks ...
BlueStem Wealth Partners disclosed a substantial new stake in VictoryShares Short-Term Bond ETF (USTB) during the lat...
Google’s Gemini AI signals a potential XRP rally by late June 2026, citing two concrete regulatory moves as catalysts...
Ripple won a preliminary CASP license from Luxembourg under MiCA, a key step in its EU expansion. The license is not ...
Swell has halted its Swellchain on the Optimism Superchain, leaving users scrambling to recover assets as the latest ...
A convicted money launderer allegedly routed about $290,000 in crypto after a court ordered asset forfeiture, highlig...
Galaxy Digital warns the CLARITY Act may stall in 2026 without a timely committee vote, with lawmakers juggling other...
U.S. stock indexes pushed higher Friday, extending gains as AI leaders and mega-cap tech names drive valuations highe...